Strategic Partnership Vivior recently divested assets to Zeiss, indicating a shift in strategic focus and potential collaborations with major ophthalmic players. This presents an opening to pursue formal partnerships or licensing agreements leveraging their Vision Behaviour Monitor technology.

Clinical Adoption With a medical advisory board and proven concept testing, Vivior’s technology is positioned for adoption by ophthalmic surgeons, optometrists, and clinics. Targeted outreach to eye care networks and hospital systems could drive early pilot programs and data collaborations.

Monetization Path Current revenue is in a low range, suggesting opportunities to explore commercial models such as device-as-a-service, cloud data analytics subscriptions, or integration fees with existing intraocular lens or refractive surgery providers.

Allied Partnerships Longstanding collaborations with gaming and media-oriented ventures (GameSquare, Ninja Labs) indicate a capability to partner across diverse ecosystems. This could enable consumer-facing trials, awareness campaigns, or pilot programs in augmented reality spectacle markets.

Expansion Readiness Recent activity and IP development imply readiness for enhanced market expansion and clinical trials. Consider opportunities in North American and European eye-care networks, academic centers, and clinical research organizations for scale-up and validation studies.